Project grant for international collaboration within Personalised Medicine (EP PerMed)

The purpose of the grant is to support international collaboration in the European Partnership for Personalised Medicine (EP PerMed), with the aim of promoting the development and implementation of personalised medicine. Sweden, via the Swedish Research Council, is one of the countries taking part in the EP PerMed call 'Personalised Medicine for CARdiovascular, MEtabolic, and KidNey diseases (CARMEN2026)'. This grant supports Swedish researchers participating in international consortia of 3-6 partners from at least 3 participating countries. Applicants must submit parallel applications both to the EP PerMed consortium system and to the Swedish Research Council's Prisma system. The grant covers all project-related costs including salaries, premises, running costs, and depreciation costs over a 3-year period. Swedish participation requires a minimum funding of 1.2 million SEK, with a maximum of 3 million SEK for one Swedish partner or 4.5 million SEK total for two Swedish partners in the same consortium. The application process follows a two-stage procedure with outline applications reviewed first, followed by invited full applications.